arrow
G

German Ott

robert bosch krankenhaus
H指数:122
被引数:7.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms

新生抗原受体ROR1通过多样化和互补机制促进细胞生长

Leukemia
IF13.4
2026-10-140
OAAI
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma

通过MYC抑制miR-29会导致转化性滤泡性淋巴瘤中CD40信号增强

Leukemia
IF13.4
2026-02-190
OA
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP

Perforin 1 A91V胚系背景对接受R-CHOP治疗的侵袭性B-NHL患者的影响

2025-12-070
OA
Cyclin D1 rearranged diffuse large B-cell lymphoma—an evolving concept

Cyclin D1 rearranged diffuse large B-cell lymphoma——一个不断发展的概念

Leukemia
IF13.4
2025-11-070
PRE
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study

德国非小细胞肺癌(NSCLC)化疗免疫联合治疗后病理反应评估的当前实践:来自多中心Re-GraDE研究的第一批真实世界数据

2025-09-050
OAAI
Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC Rearrangement

MYC阳性与MYC阴性11q异常的高级别B细胞淋巴瘤的细胞基因组学和临床病理学比较,并与其他具有MYC重排的侵袭性淋巴瘤进行比较

2025-05-100
OAAI
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA

弥漫大B细胞淋巴瘤的年龄和性别特异性分子特征:来自DSHNHL/GLA临床 trial 的结果

2025-03-070
OAAI
A Systematic Approach to Prioritise Diagnostically Useful Findings for Inclusion in Electronic Health Records as Discrete Data to Improve Clinical Artificial Intelligence Tools and Genomic Research

一种系统的方法,优先考虑诊断有用的发现,将其作为离散数据纳入电子健康记录,以改善临床人工智能工具和基因组研究

2025-03-010
OAAI
The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study

间变性大细胞淋巴瘤的表型景观支持新的分子分类: 一项LLMPP研究

2025-03-010
PRE
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

使用多参数方法细化外周T细胞淋巴瘤的诊断亚型

2025-02-010
PRE
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration

MicroRNA在11q畸变高级别b细胞淋巴瘤中的表达

2025-01-230
OAAI
Immune Cell Infiltration Impacts Chemotherapy Efficacy in B-NHL

免疫细胞浸润影响B-NHL的化疗疗效

BLOOD
IF23.1
2024-11-050
PRE
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration
LEUKEMIA
IF13.4
2024-08-160
PRE
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
2024-08-151
OAAI
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress

抑制DLBCL中的glutaminase-1通过促进氧化应激增强维奈托克诱导的抗肿瘤活性

2023-12-131
OAAI
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma
LEUKEMIA
IF13.4
2023-08-303
OAAI